Novartis AG
NYSE:NVS · New York Stock Exchange
-$3.38 today
Vol 1.67M · Avg 1.56M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+27.59%
Period High
$165.40
Period Low
$111.34
Latest
$147.08
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Eli Lilly and Company
NYSE:LLY
$1.04T
Johnson & Johnson
NYSE:JNJ
$552.00B
AbbVie Inc.
NYSE:ABBV
$382.43B
Roche Holding AG
RHHBY
$320.68B
Merck & Co., Inc.
NYSE:MRK
$281.88B
AstraZeneca PLC
NYSE:AZN
$271.19B
Gilead Sciences, Inc.
NASDAQ:GILD
$152.51B
Pfizer Inc.
NYSE:PFE
$143.80B
Bristol-Myers Squibb Company
NYSE:BMY
$110.07B
GSK plc
NYSE:GSK
$101.97B
Sanofi
NASDAQ:SNY
$101.45B
Bayer AG
BAYRY
$41.62B
What is the latest NVS filing?
The latest filing shown is 6-K dated Jun 11, 2026.
How many recent filings does NVS have?
Intrinsic Alpha currently shows 20 recent filings for NVS.
Explore More
Continue the stock analysis
Jump to another research area for this company.